ABCG2 and neoplasm: However, its use in clinical practice is limited due to the cumulative lifetime cardiotoxicity, which is mainly caused by the excessive production of superoxide anions in cardiomyocytes [34], and rapid development of ABC transporter-mediated resistance in tumor cells [35,36].